Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial

OBJECTIVE: A multiarm Phase I clinical trial was performed to define the maximum tolerated dose (MTD) of stereotactic body radiotherapy (SBRT) delivered by non-coplanar conformal beams or volumetric modulated arc therapy technique in seven predefined clinical settings. METHODS: The (a) and (b) arms...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Radiol
Autors principals: Deodato, Francesco, Macchia, Gabriella, Cilla, Savino, Ianiro, Anna, Sallustio, Giuseppina, Cammelli, Silvia, Buwenge, Milly, Mattiucci, Gian Carlo, Valentini, Vincenzo, Morganti, Alessio G
Format: Artigo
Idioma:Inglês
Publicat: The British Institute of Radiology. 2019
Matèries:
Full Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6404833/
https://ncbi.nlm.nih.gov/pubmed/30325662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20180422
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars